Delivery Order SPE2DB24D3013-SPE2DB25FFLWF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $1,446.40. This competitively awarded, firm fixed-price delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This award carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $5,600.41. This non-competitive, firm fixed-price delivery order was awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $34,423.81. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $11,985.90. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $20,757.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, which is classified as a child award under a larger vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Multaq 400 mg tablets (60-count units) valued at $1,725.96. This firm fixed price delivery order, issued on August 14, 2025, with completion targeted for August 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was made through open competition with no set-aside designation, and performance will be fulfilled from the...
- The Defense Logistics Agency awarded a $3,405.18 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count). The contract is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded transaction, reflecting the contractor's established capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count) valued at $7,313.70 under a firm fixed price contract. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen will perform this delivery order from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) valued at $3,359.77, with an ultimate completion date of September 11, 2025. This competitive award, issued September 10, 2025, utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a $46,648.43 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac care. The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and was awarded on September 8, 2025. This award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. The work will be performed at AmerisourceBergen's...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFLWFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count) with a ceiling value of $1,156.43. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 20, 2025. The award was issued on May 19, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, and specialized medical commodities across multiple therapeutic domains. AmerisourceBergen's status as a major pharmaceutical distributor and healthcare solutions provider positions it as a critical vendor for federal medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/19/25 |